Explore our focus areas

We work with life science clients to look at the broader value of medicines and health, re-aligning how health technology assessment bodies and governments value medicines and the value of health to patients, populations, and economies.

We help clients address health inequalities by identifying and implementing health equity strategies into evidence generation strategies, and developing market access strategies aligned with commercial goals and payer needs.

We support pharmaceutical companies in navigating obesity treatment market challenges, from ensuring robust clinical development programs to creating compelling value narratives and real-world evidence that resonates with payers and HTA bodies.